These success, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 support the strategy of focusing on ACKR3 as a novel method to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Conditions. As well as the explained https://hillaryv581zwr1.mappywiki.com/user